MedPage Today on MSN
GLP-1 Microdosing and Longevity; Near 30% Weight Loss in Trial; 2025's Top Research
Meanwhile, people with overweight or obesity lost up to 11.3% more weight than placebo by week 36 with a novel GLP-1 agonist ...
People who brought their blood glucose down to a normal level had a lower risk of death from heart disease or hospitalization ...
Continuous glucose monitoring may have a role in identifying and preventing diabetes among healthy adults, but more studies ...
At the San Antonio Breast Cancer Symposium, researchers reported that real-time monitoring with smart pill bottles ...
In an international study led by UCLA, researchers have shown that giredestrant, a next-generation oral selective estrogen ...
Giredestrant, a selective estrogen receptor antagonist and degrader given as an adjuvant therapy, shows significant ...
Thyroid disorders, common endocrine conditions, often require long-term management. Shivkumar Aggarwal, seeking lasting ...
Erika Mayer, MD, MPH, Dana-Farber Cancer Institute, discusses the exciting findings of the phase 3 lidERA study investigating ...
Automated insulin delivery systems can help pregnant women with type 1 diabetes manage their glucose during gestation.
Inflammatory and hyperinsulinemic diets raise the risk of type 2 diabetes (T2D) in women with a history of gestational diabetes.
Prediabetic patients, who lower their blood sugar levels and can achieve remission, can reduce the likelihood of serious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results